Skip to main content
Day.News — Local News. Real Community.
BLEDSOE COUNTY DAY NEWS
Local News. Real Community.

Health & Wellness

09/08/2026 · Bledsoe County

Full Edition
Peer-Reviewed Study Reports on New Blood Test for Early Breast Cancer Detection

Peer-Reviewed Study Reports on New Blood Test for Early Breast Cancer Detection

A new peer-reviewed study details a blood test for early-stage breast cancer, reporting over 92% sensitivity and specificity. Researchers indicate the test's performance surpasses current supplemental screening methods. The study comes from a team at Astrin Biosciences.

08/23/2026
Read Story
Health

FDA Approves Subcutaneous Lecanemab for Early Alzheimer's Treatment

The Food and Drug Administration has approved LEQEMBI IQLIK (lecanemab-irmb), a subcutaneous injection for early Alzheimer's disease. This formulation allows for at-home dosing, broadening administration options for patients.

08/21/2026 · Tennessee

Health

Survey Identifies Generational Differences in Healthcare System Perceptions

A recent national survey reveals differences in how age groups perceive the U.S. healthcare system. Gen Z and Millennial voters more frequently identified systemic failures, especially regarding women's health services.

08/21/2026 · Tennessee

Health

FDA Approves Subcutaneous Leqembi Starting Dose for Alzheimer's Treatment

The FDA has approved a weekly subcutaneous starting dose for Leqembi, a drug for early Alzheimer's. This approval provides an alternative administration method for patients. The Alzheimer's Drug Discovery Foundation commented on the development.

08/19/2026 · Tennessee

Health

Home Oxygen Access Challenges Delay Hospital Discharges Nationwide

A recent national survey indicates that restricted access to high-flow home oxygen equipment prolongs patient stays in hospitals. These delays reportedly increase both financial burdens and health risks for individuals. The issue also impacts healthcare system costs.

07/29/2026 · Tennessee

Health

FDA Approves Oral PCSK9 Inhibitor for Cholesterol Reduction

The U.S. Food and Drug Administration has approved Lipfendra (enlicitide), an oral medication designed to lower LDL cholesterol. This approval marks the first time an oral PCSK9 inhibitor has received authorization for use in adults with high cholesterol.

07/27/2026 · Tennessee

More Health & Wellness

Sponsored

Advertisement

Advertisement

Advertisement